Czech Republic Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Czech Republic Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

on

  • 181 views

 

Statistics

Views

Total Views
181
Views on SlideShare
181
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Czech Republic Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery Document Transcript

  • 1. Czech Republic Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 93Price: Single User License – US$2500Czech Republic Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and InsulinDeliverySummaryGlobalData’s new report, “Czech Republic Diabetes Care Devices Market Outlook to 2018 -Glucose Monitoring and Insulin Delivery” provides key market data on the Czech RepublicDiabetes Care Devices market. The report provides value (USD million), volume (units) andaverage price (USD) data for each segment and sub-segment within two market categories –Glucose Monitoring and Insulin Delivery. The report also provides company shares anddistribution shares data for each of the aforementioned market categories. The report issupplemented with global corporate-level profiles of the key market participants with informationon company financials and pipeline products, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Czech Republic DiabetesCare Devices market.- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi , LifeScan, Inc., Eli Lilly andCompany , Novo Nordisk A/S , Bayer HealthCare AG and others.
  • 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Czech Republic DiabetesCare Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197502-czech-republic-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 51.2 List of Figures 62 Introduction 82.1 What is This Report About? 83 Diabetes Care Devices In Czech Republic 93.1 Diabetes Care Devices, Market Segmentation 93.2 Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, 2004-2018 103.3 Diabetes Care Devices Market, Czech Republic, Revenue Mix ($m), 2011 113.4 Diabetes Care Devices Market, Czech Republic, Category Contribution (%), 2011 123.5 Diabetes Care Devices, Czech Republic, Company Share (2010-2011) 194 Glucose Monitoring In Czech Republic 214.1 Glucose Monitoring, Market Segmentation 214.2 Glucose Monitoring Market, Czech Republic, Revenue Mix ($m), 2011 224.3 Glucose Monitoring Market, Czech Republic, Segment Contribution (%), 2011 234.4 Glucose Monitoring Overall Revenue, (2004-2018) 244.4.1 Blood Glucose Meters, Revenue (2004-2018) 284.5 Glucose Monitoring Overall Volume (2004-2018) 324.5.1 Blood Glucose Meters, Volume (2004-2018) 364.6 Glucose Monitoring Average Price (2004-2018) 404.7 Glucose Monitoring Distribution Share (2010-2011) 414.8 Glucose Monitoring, Czech Republic, Company Share (2010-2011) 425 Insulin Delivery In Czech Republic 445.1 Insulin Delivery, Market Segmentation 44
  • 3. 5.2 Insulin Delivery Market, Czech Republic, Revenue Mix ($m), 2011 455.3 Insulin Delivery Market, Czech Republic, Segment Contribution (%), 2011 465.4 Insulin Delivery Overall Revenue, (2004-2018) 475.4.1 Insulin Pens, Revenue (2004-2018) 515.4.2 Insulin Pumps, Revenue (2004-2018) 555.5 Insulin Delivery Overall Volume (2004-2018) 575.5.1 Insulin Pens, Volume (2004-2018) 615.5.2 Insulin Pumps, Volume (2004-2018) 655.6 Insulin Delivery Average Price (2004-2018) 675.7 Insulin Delivery Distribution Share (2010-2011) 685.8 Insulin Delivery, Czech Republic, Company Share (2010-2011) 696 Overview of Key Companies in Czech Republic Diabetes Care Devices Market 716.1 F. Hoffmann-La Roche Ltd. 716.1.1 Company Overview 716.1.2 Share in the Czech Republic Diabetes Care Devices Market 716.2 Sanofi 726.2.1 Company Overview 726.2.2 Share in the Czech Republic Diabetes Care Devices Market 726.3 LifeScan, Inc. 736.3.1 Company Overview 736.3.2 Share in the Czech Republic Diabetes Care Devices Market 736.4 Eli Lilly and Company 746.4.1 Company Overview 746.4.2 Share in the Czech Republic Diabetes Care Devices Market 746.5 Novo Nordisk A/S 756.5.1 Company Overview 756.5.2 Share in the Czech Republic Diabetes Care Devices Market 756.6 Bayer HealthCare AG 766.6.1 Company Overview 766.6.2 Share in the Czech Republic Diabetes Care Devices Market 766.7 Abbott Laboratories 776.7.1 Company Overview 776.8 Medtronic, Inc. 776.8.1 Company Overview 776.9 Becton, Dickinson and Company 786.9.1 Company Overview 786.10 Ypsomed Holding AG 786.10.1 Company Overview 786.11 Terumo Corporation 796.11.1 Company Overview 796.12 Animas Corporation 796.12.1 Company Overview 79
  • 4. 6.13 Nipro Corporation 796.13.1 Company Overview 797 Diabetes Care Devices Market Pipeline Products 808 Financial Deals Landscape 848.1 Partnerships 848.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 848.1.2 Insulet Amends Licensing Agreement With Abbott Diabetes 859 Appendix 869.1 Definitions of Markets Covered in the Report 879.1.1 Diabetes Care Devices 879.2 Research Methodology 909.3 Secondary Research 909.4 Primary Research 919.5 Models 919.6 Forecasts 929.7 Expert Panels 929.8 GlobalData Consulting 929.9 Currency Conversion 939.10 Contact Us 939.11 Disclaimer 931.1 List of TablesTable 1: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, 2004-2018 10Table 2: Diabetes Care Devices Market, Czech Republic, Category Contribution (%), 2011 12Table 3: Diabetes Care Devices, Czech Republic, Cross-Segment Analysis, 2004-2018 14Table 4: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, Historic,2004-2011 16Table 5: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant,Forecast, 2011-2018 18Table 6: Diabetes Care Devices, Czech Republic, Company Share by Revenue ($m), USDConstant, 2010-2011 20Table 7: Glucose Monitoring Market, Czech Republic, Segment Contribution (%), 2011 23Table 8: Glucose Monitoring, Czech Republic, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 25Table 9: Glucose Monitoring, Czech Republic, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 27Table 10: Blood Glucose Meters, Czech Republic, Revenue ($m*) USD Constant, by Sub-Segment, Historic, 2004-2011 29Table 11: Blood Glucose Meters, Czech Republic, Revenue ($m*) USD Constant, by Sub-Segment, Forecast, 2011-2018 31Table 12: Glucose Monitoring, Czech Republic, Volume (Units) by Segment, Historic, 2004-2011
  • 5. 33Table 13: Glucose Monitoring, Czech Republic, Volume (Units) by Segment, Forecast, 2011-201835Table 14: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment, Historic,2004-2011 37Table 15: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment, Forecast,2011-2018 39Table 16: Glucose Monitoring, Czech Republic, Average Price ($), Historic, 2004-2011 40Table 17: Glucose Monitoring, Czech Republic, Average Price ($), Forecast, 2011-2018 40Table 18: Glucose Monitoring, Czech Republic, Distribution Share by Revenue ($m), USDConstant, 2010-2011 41Table 19: Glucose Monitoring, Czech Republic, Company Share by Revenue ($m), USD Constant,2010-2011 43Table 20: Insulin Delivery Market, Czech Republic, Segment Contribution (%), 2011 46Table 21: Insulin Delivery, Czech Republic, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 48Table 22: Insulin Delivery, Czech Republic, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 50Table 23: Insulin Pens, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 52Table 24: Insulin Pens, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 54Table 25: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Revenue ($m) USDConstant, Historic, 2004-2011 55Table 26: Insulin Pumps, Czech Republic, Revenue ($m) USD Constant, Forecast, 2011-2018 56Table 27: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Historic, 2004-2011 58Table 28: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Forecast, 2011-2018 60Table 29: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Historic, 2004-2011 62Table 30: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Forecast, 2011-2018 64Table 31: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume (Units), Historic,2004-2011 65Table 32: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume (Units) by Sub-Segment, Forecast, 2011-2018 66Table 33: Insulin Delivery, Czech Republic, Average Price ($), Historic, 2004-2011 67Table 34: Insulin Delivery, Czech Republic, Average Price ($), Forecast, 2011-2018 67Table 35: Insulin Delivery, Czech Republic, Distribution Share by Revenue ($m), USD Constant,2010-2011 68Table 36: Insulin Delivery, Czech Republic, Company Share by Revenue ($m), USD Constant,2010-2011 70Table 37: Diabetes Care DevicesMarket Pipeline Products 80Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 84Table 39: Insulet Amends Licensing Agreement With Abbott Diabetes 85
  • 6. 1.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 9Figure 2: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, 2004-2018 10Figure 3: Diabetes Care Devices Market, Czech Republic, Revenue Mix ($m), 2011 11Figure 4: Diabetes Care Devices Market, Czech Republic, Category Contribution (%), 2011 12Figure 5: Diabetes Care Devices, Czech Republic, Cross-Segment Analysis, 2004-2018 13Figure 6: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant, Historic,2004-2011 15Figure 7: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Constant,Forecast, 2011-2018 17Figure 8: Diabetes Care Devices, Czech Republic, Company Share (%), 2011 19Figure 9: Glucose Monitoring, Market Segmentation 21Figure 10: Glucose Monitoring Market, Czech Republic, Revenue Mix ($m), 2011 22Figure 11: Glucose Monitoring Market, Czech Republic, Segment Contribution (%), 2011 23Figure 12: Glucose Monitoring, Czech Republic, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 24Figure 13: Glucose Monitoring, Czech Republic, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 26Figure 14: Blood Glucose Meters, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 28Figure 15: Blood Glucose Meters, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 30Figure 16: Glucose Monitoring, Czech Republic, Volume (Units) by Segment, Historic, 2004-201132Figure 17: Glucose Monitoring, Czech Republic, Volume (Units) by Segment, Forecast, 2011-201834Figure 18: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment, Historic,2004-2011 36Figure 19: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment, Forecast,2011-2018 38Figure 20: Glucose Monitoring, Czech Republic, Company Share (%), 2011 42Figure 21: Insulin Delivery, Market Segmentation 44Figure 22: Insulin Delivery Market, Czech Republic, Revenue Mix ($m), 2011 45Figure 23: Insulin Delivery Market, Czech Republic, Segment Contribution (%), 2011 46Figure 24: Insulin Delivery, Czech Republic, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 47Figure 25: Insulin Delivery, Czech Republic, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 49Figure 26: Insulin Pens, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 51
  • 7. Figure 27: Insulin Pens, Czech Republic, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 53Figure 28: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Revenue ($m) USDConstant, Historic, 2004-2011 55Figure 29: Insulin Pumps, Czech Republic, Revenue ($m) USD Constant, Forecast, 2011-2018 56Figure 30: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Historic, 2004-2011 57Figure 31: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Forecast, 2011-2018 59Figure 32: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Historic, 2004-2011 61Figure 33: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Forecast, 2011-201863Figure 34: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume (Units), Historic,2004-2011 65Figure 35: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume (Units), Forecast,2011-2018 66Figure 36: Insulin Delivery, Czech Republic, Company Share (%), 2011 69Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),Czech Republic Diabetes CareDevices Market, 2011 71Figure 38: Sanofi, Company Share (%),Czech Republic Diabetes Care Devices Market, 2011 72Figure 39: LifeScan, Inc., Company Share (%),Czech Republic Diabetes Care Devices Market,2011 73Figure 40: Eli Lilly and Company, Company Share (%),Czech Republic Diabetes Care DevicesMarket, 2011 74Figure 41: Eli Lilly and Company, Company Share (%),Czech Republic Diabetes Care DevicesMarket, 2011 75Figure 42: Bayer HealthCare AG, Company Share (%),Czech Republic Diabetes Care DevicesMarket, 2011 76Contact: sales@reportsandreports.com for more information.